Skip to main content
. 2022 Feb 25;9:854570. doi: 10.3389/fmed.2022.854570

Table 3.

Four serum markers and CHI3L1 in the control and OSA subgroups.

Variables Control (n = 20) OSA (n = 74)
Mild OSA (n = 15) Moderate OSA (n = 24) Severe OSA (n = 35)
HA (ng/ml) 23.62 ± 5.93 33.12 ± 10.6* 34.53 ± 13.2* 35.44 ± 10.7**
PIIINP (ng/ml) 7.384 ± 1.69 7.12 ± 2.28 7.368 ± 2.24 8.32 ± 3.1
CIV (ng/ml) 41.78 ± 8.72 37.41 ± 4.57 39.55 ± 3.46 45.52 ± 2.45*
LN (ng/ml) 27.29 ± 6.39 27.37 ± 7.69 29.12 ± 7.92 30.48 ± 7.4
CHI3L1 (ng/ml) 34.45 (26.7, 41.3) 35.42 (29.42, 41.2) 37.88 (29.9, 51.2) 40.35 (31.9, 54.9)*

HA, hyaluronan; PIIINP, procollagen type III N-terminal peptide; CIV, type IV collagen; LN, laminin; CHI3L1, Chitinase-3-like protein 1.

*

p < 0.05, compared with the control group.

**

p < 0.001, compared with the control group.